Apr 06, 2020
The Lancet Simultaneously Publishes Two Phase 3 Studies Detailing Comprehensive Efficacy and Safety of TREMFYA® (guselkumab), a First-in-Class IL-23 p19 Subunit Inhibitor, in Psoriatic Arthritis
Apr 01, 2020
Global Systemic Lupus Erythematosus Report, 10-Year Forecasts, 7MM Coverage and Detailed Pipeline Product Profiles
Mar 31, 2020
InDex Pharmaceuticals Receives Grant From Vinnova for Pre-clinical Development of DIMS Compounds in Inflammation
Mar 30, 2020
Lilly's Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
Mar 23, 2020
Prometheus Biosciences Launches Monitr(TM) COVID-19 Assistance Program (M.C.A.P.)
Mar 20, 2020
New Research Among People Living With Rheumatoid Arthritis Reveals Key Determinants Of Patient Satisfaction With Doctors
Mar 12, 2020
Provention Announces Positive Data from Phase 1b PREVAIL Study of PRV-3279
Mar 09, 2020
The psoriatic arthritis treatment market was valued at $7,860 million in 2018, and is estimated to reach at $13,744 million by 2026, registering a CAGR of 7.2% from 2019 to 2026
Mar 06, 2020
Psoriatic Arthritis: Global Drug Forecast and Market Analysis to 2028
Mar 04, 2020
Mallinckrodt Announces Publication of New Data on Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis, Systemic Lupus Erythematosus and Dermatomyositis/Polymyositis Published in Open Access Rheumatology: Research and Reviews
Feb 25, 2020
Connect Biopharma Enhances its Intellectual Property Estate for CBP-307, a Targeted Therapy with Potential in Multiple Autoimmune Diseases, with Patent Issuances in the United States, EU, Japan and Australia
Feb 25, 2020
InDex Pharmaceuticals Publishes Mechanism of Action Data for Cobitolimod in Scientific Journal
Feb 24, 2020
Latest Development, Product Innovations and Treatments for Diabetes
Feb 19, 2020
New Data Show Oral Ferric Maltol (FERACCRU®) May Be a Cost-effective Alternative to Intravenous (IV) Carboxymaltose With at Least as Great Benefits in the Quality of Life of Patients With Iron Deficiency Anaemia and Inflammatory Bowel Disease
Feb 19, 2020
Global Optic Nerve Diseases Pipeline Study, 2020: Treatment, Products, Drugs, Key Players
Feb 19, 2020
ChemomAb Ltd. Announces Issuance of Composition of Matter Patent for CM-101 and Reinforces its IP Portfolio
Feb 19, 2020
InDex Pharmaceuticals' In-depth Analysis of the CONDUCT Study Confirms the Successful Top Line Results and Supports the Strategy Going Forward
Feb 18, 2020
Clarify Medical Now Approved as a TRICARE® Participating Provider
Feb 18, 2020
Arthritis Foundation Releases Findings From One of the Nation's Largest Assessments of People With Arthritis
Feb 14, 2020
New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn's Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab)